Oncodesign Precision Medicine (XPAR:ALOPM) Other Long Term Assets : €0.33 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Other Long Term Assets?

Oncodesign Precision Medicine's other long-term assets for the quarter that ended in Dec. 2024 was €0.33 Mil.

Oncodesign Precision Medicine's quarterly other long-term assets declined from Dec. 2023 (€0.32 Mil) to Jun. 2024 (€0.00 Mil) but then increased from Jun. 2024 (€0.00 Mil) to Dec. 2024 (€0.33 Mil).

Oncodesign Precision Medicine's annual other long-term assets increased from Dec. 2022 (€0.27 Mil) to Dec. 2023 (€0.32 Mil) and increased from Dec. 2023 (€0.32 Mil) to Dec. 2024 (€0.33 Mil).

Oncodesign Precision Medicine Other Long Term Assets Historical Data

The historical data trend for Oncodesign Precision Medicine's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Other Long Term Assets Chart

Oncodesign Precision Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

0.02

0.27

0.32

0.33

Oncodesign Precision Medicine Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial			0.27	0.31	0.32	-	0.33

Oncodesign Precision Medicine Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Oncodesign Precision Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ZR8:Germany

Address

18 rue Jean Mazen, Dijon, FRA, 21000

Website

https://www.opm.oncodesign.com

Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine Headlines

No Headlines